Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

Author: Ueda Seiji   Yamagishi Sho-ichi   Matsumoto Yuriko   Fukami Kei   Okuda Seiya  

Publisher: Springer Publishing Company

ISSN: 1342-1751

Source: Clinical and Experimental Nephrology, Vol.11, Iss.2, 2007-06, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content